ALDURAZYME
Active substance: laronidase
INJECTION, SOLUTION, CONCENTRATE · LARONIDASE 2.9 mg/5mL
United StatesActive
Marketing holder: Genzyme Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LARONIDASE · 2.9 mg/5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12098-db0a-7716-9ec4-6db26119a8dd;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 58468-0070
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 58468-0070 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58468-0070 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58468-0070 · Verified 2026-10-09 · open in source